Bioassay at Uranium Mills, 14837 [2012-6001]

Download as PDF Federal Register / Vol. 77, No. 49 / Tuesday, March 13, 2012 / Notices Commission, Washington, DC 20555– 0001; telephone: 301–251–7404; or email Richard.Jervey@nrc.gov. SUPPLEMENTARY INFORMATION: NUCLEAR REGULATORY COMMISSION [NRC–2012–0057] Bioassay at Uranium Mills Nuclear Regulatory Commission. ACTION: Draft regulatory guide; request for comment. AGENCY: The U.S. Nuclear Regulatory Commission (NRC or the Commission) is issuing for public comment draft regulatory guide (DG), DG–8051, ‘‘Bioassay at Uranium Mills.’’ This guide describes a bioassay program acceptable to the NRC staff for uranium mills and applicable portions of uranium conversion facilities where the possibility of exposure to yellowcake dust exists, including exposure conditions with and without the use of respiratory protection devices. DATES: Submit comments by May 11, 2012. Comments received after this date will be considered if it is practical to do so, but the NRC is able to ensure consideration only for comments received on or before this date. Although a time limit is given, comments and suggestions in connection with items for inclusion in guides currently being developed or improvements in all published guides are encouraged at any time. ADDRESSES: You may access information and comment submissions related to this document, which the NRC possesses and is publicly available, by searching on https://www.regulations.gov under Docket ID NRC–2012–0057. You may submit comments by the following methods: • Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC–2012–0057. Address questions about NRC dockets to Carol Gallagher; telephone: 301–492–3668; email: Carol.Gallagher@nrc.gov. • Mail comments to: Cindy Bladey, Chief, Rules, Announcements, and Directives Branch (RADB), Office of Administration, Mail Stop: TWB–05– B01M, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001. • Fax comments to: RADB at 301– 492–3446. For additional direction on accessing information and submitting comments, see ‘‘Accessing Information and Submitting Comments’’ in the SUPPLEMENTARY INFORMATION section of this document. FOR FURTHER INFORMATION CONTACT: R. A. Jervey, Office of Nuclear Regulatory Research, U.S. Nuclear Regulatory mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 18:29 Mar 12, 2012 Jkt 226001 I. Accessing Information and Submitting Comments A. Accessing Information Please refer to Docket ID NRC–2012– 0057 when contacting the NRC about the availability of information regarding this document. You may access information related to this document, which the NRC possesses and is publicly available, by the following methods: • Federal Rulemaking Web Site: Go to https://www.regulations.gov and search for Docket ID NRC–2012–0057. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may access publicly available documents online in the NRC Library at https://www.nrc.gov/readingrm/adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The draft regulatory guide is available under ADAMS accession No. ML110960333. The regulatory analysis may be found in ADAMS under accession No. ML110960341. Regulatory guides are not copyrighted, and NRC approval is not required to reproduce them. II. Further Information The NRC is issuing for public comment a draft guide in the agency’s ‘‘Regulatory Guide’’ series. This series was developed to describe and make available to the public such information as methods that are acceptable to the NRC staff for implementing specific parts of the NRC’s regulations, techniques that the staff uses in evaluating specific problems or postulated accidents, and data that the staff needs in its review of applications for permits and licenses. The draft regulatory guide, entitled, ‘‘Bioassay at Uranium Mills,’’ is temporarily identified by its task number, DG–8051, which should be mentioned in all related correspondence. DG–8051 is proposed Revision 2 of Regulatory Guide 8.22, previously revised in August 1988. This guide is being updated to incorporate changes made in 10 CFR Part 20 since Regulatory Guide 8.22, Revision 1 was issued. Comments related to the operation of in-situ PO 00000 Frm 00114 Fmt 4703 Sfmt 4703 14837 recovery mills and associated considerations for bioassay are of particular interest. Dated at Rockville, Maryland, this 6th day of March, 2012. For the Nuclear Regulatory Commission. Thomas H. Boyce, Chief, Regulatory Guide Development Branch, Division of Engineering, Office of Nuclear Regulatory Research. [FR Doc. 2012–6001 Filed 3–12–12; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission. ACTION: Notice of meeting. AGENCY: NRC will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April 16–17, 2012. A sample of agenda items to be discussed during the public session includes: (1) Fundamental concepts in patient advocacy; (2) electronic signatures for documents that are required to be signed in accordance with U.S. Nuclear Regulatory Commission (NRC) regulations; (3) medical-related events from fiscal year 2011; (4) an update on proposed regulatory changes for Permanent Implant Brachytherapy programs; (5) the status of the Commission Paper on data collection for Patient Release; (6) a status update on 10 CFR Part 35 rulemaking; (7) medical use of radium223 chloride; (8) an update on strontium breakthrough with rubidium-82 generators from NRC and FDA perspectives; and (9) half-life activity as a function of solar activity. The agenda is subject to change. The current agenda and any updates will be available at https://www.nrc.gov/reading-rm/doccollections/acmui/agenda or by emailing Ms. Sophie Holiday at the contact information below. Purpose: Discuss issues related to 10 CFR Part 35 Medical Use of Byproduct Material. Date and Time for Closed Session: April 16, 2012, from 8 a.m. to 10:45 a.m. This session will be closed so that ACMUI members can prepare for an upcoming Commission briefing. Date and Time for Open Sessions: April 16, 2012, from 10:45 a.m. to 5 p.m. and April 17, 2012, from 8 a.m. to 12:30 p.m. Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two White Flint North Building, Room T2– SUMMARY: E:\FR\FM\13MRN1.SGM 13MRN1

Agencies

[Federal Register Volume 77, Number 49 (Tuesday, March 13, 2012)]
[Notices]
[Page 14837]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-6001]



[[Page 14837]]

=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2012-0057]


Bioassay at Uranium Mills

AGENCY: Nuclear Regulatory Commission.

ACTION: Draft regulatory guide; request for comment.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC or the Commission) 
is issuing for public comment draft regulatory guide (DG), DG-8051, 
``Bioassay at Uranium Mills.'' This guide describes a bioassay program 
acceptable to the NRC staff for uranium mills and applicable portions 
of uranium conversion facilities where the possibility of exposure to 
yellowcake dust exists, including exposure conditions with and without 
the use of respiratory protection devices.

DATES: Submit comments by May 11, 2012. Comments received after this 
date will be considered if it is practical to do so, but the NRC is 
able to ensure consideration only for comments received on or before 
this date. Although a time limit is given, comments and suggestions in 
connection with items for inclusion in guides currently being developed 
or improvements in all published guides are encouraged at any time.

ADDRESSES: You may access information and comment submissions related 
to this document, which the NRC possesses and is publicly available, by 
searching on https://www.regulations.gov under Docket ID NRC-2012-0057. 
You may submit comments by the following methods:
     Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC-2012-0057. Address 
questions about NRC dockets to Carol Gallagher; telephone: 301-492-
3668; email: Carol.Gallagher@nrc.gov.
     Mail comments to: Cindy Bladey, Chief, Rules, 
Announcements, and Directives Branch (RADB), Office of Administration, 
Mail Stop: TWB-05-B01M, U.S. Nuclear Regulatory Commission, Washington, 
DC 20555-0001.
     Fax comments to: RADB at 301-492-3446.
    For additional direction on accessing information and submitting 
comments, see ``Accessing Information and Submitting Comments'' in the 
SUPPLEMENTARY INFORMATION section of this document.

FOR FURTHER INFORMATION CONTACT: R. A. Jervey, Office of Nuclear 
Regulatory Research, U.S. Nuclear Regulatory Commission, Washington, DC 
20555-0001; telephone: 301-251-7404; or email Richard.Jervey@nrc.gov.

SUPPLEMENTARY INFORMATION:

I. Accessing Information and Submitting Comments

A. Accessing Information

    Please refer to Docket ID NRC-2012-0057 when contacting the NRC 
about the availability of information regarding this document. You may 
access information related to this document, which the NRC possesses 
and is publicly available, by the following methods:
     Federal Rulemaking Web Site: Go to https://www.regulations.gov and search for Docket ID NRC-2012-0057.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may access publicly available documents online in the NRC 
Library at https://www.nrc.gov/reading-rm/adams.html. To begin the 
search, select ``ADAMS Public Documents'' and then select ``Begin Web-
based ADAMS Search.'' For problems with ADAMS, please contact the NRC's 
Public Document Room (PDR) reference staff at 1-800-397-4209, 301-415-
4737, or by email to pdr.resource@nrc.gov. The draft regulatory guide 
is available under ADAMS accession No. ML110960333. The regulatory 
analysis may be found in ADAMS under accession No. ML110960341.
    Regulatory guides are not copyrighted, and NRC approval is not 
required to reproduce them.

II. Further Information

    The NRC is issuing for public comment a draft guide in the agency's 
``Regulatory Guide'' series. This series was developed to describe and 
make available to the public such information as methods that are 
acceptable to the NRC staff for implementing specific parts of the 
NRC's regulations, techniques that the staff uses in evaluating 
specific problems or postulated accidents, and data that the staff 
needs in its review of applications for permits and licenses.
    The draft regulatory guide, entitled, ``Bioassay at Uranium 
Mills,'' is temporarily identified by its task number, DG-8051, which 
should be mentioned in all related correspondence. DG-8051 is proposed 
Revision 2 of Regulatory Guide 8.22, previously revised in August 1988.
    This guide is being updated to incorporate changes made in 10 CFR 
Part 20 since Regulatory Guide 8.22, Revision 1 was issued. Comments 
related to the operation of in-situ recovery mills and associated 
considerations for bioassay are of particular interest.

    Dated at Rockville, Maryland, this 6th day of March, 2012.
    For the Nuclear Regulatory Commission.
Thomas H. Boyce,
Chief, Regulatory Guide Development Branch, Division of Engineering, 
Office of Nuclear Regulatory Research.
[FR Doc. 2012-6001 Filed 3-12-12; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.